Compare LIND & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIND | ABCL |
|---|---|---|
| Founded | 1979 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.2M | 1.1B |
| IPO Year | 2011 | 2020 |
| Metric | LIND | ABCL |
|---|---|---|
| Price | $17.61 | $3.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $22.25 | $7.75 |
| AVG Volume (30 Days) | 761.8K | ★ 2.8M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 5.97 | ★ 10.91 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $75,128,000.00 |
| Revenue This Year | $10.55 | N/A |
| Revenue Next Year | $6.34 | $16.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 160.56 |
| 52 Week Low | $7.45 | $1.89 |
| 52 Week High | $21.23 | $6.52 |
| Indicator | LIND | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 44.87 | 47.65 |
| Support Level | $11.27 | $3.37 |
| Resistance Level | $21.23 | $3.84 |
| Average True Range (ATR) | 0.84 | 0.16 |
| MACD | -0.20 | 0.00 |
| Stochastic Oscillator | 39.13 | 15.96 |
Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.